The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guerin: What should Be the Treatment and Follow Up?

Turker P., Turkeri L.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.13, sa.2, ss.103-108, 2014 (ESCI) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 13 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.4274/uob.09
  • Dergi Adı: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Sayfa Sayıları: ss.103-108
  • Anahtar Kelimeler: BBCG, high risk non-muscle invasive bladder cancer, EMDA, thermo-chemotherapy
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Bacillus Calmette Guerin (BCG), is the optimal bladder-sparing treatment option for patients with high-risk, non-muscle invasive bladder cancer. Recently, the application of BCG has been hindered due to the problem of its availability in Turkey. Alternative treatment options are needed until this problem is solved. In this article, the recommendations about the preferred treatment options and the follow-up, are summarized in the light of the current literature.